nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—Carcinoma—Cyclosporine—focal segmental glomerulosclerosis	0.0433	0.0433	CcSEcCtD
Tizanidine—Skin cancer—Cyclosporine—focal segmental glomerulosclerosis	0.0422	0.0422	CcSEcCtD
Tizanidine—Traumatic liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.0351	0.0351	CcSEcCtD
Tizanidine—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.0344	0.0344	CcSEcCtD
Tizanidine—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.0271	0.0271	CcSEcCtD
Tizanidine—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.023	0.023	CcSEcCtD
Tizanidine—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.0213	0.0213	CcSEcCtD
Tizanidine—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0181	0.0181	CcSEcCtD
Tizanidine—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.0174	0.0174	CcSEcCtD
Tizanidine—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.0169	0.0169	CcSEcCtD
Tizanidine—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0168	0.0168	CcSEcCtD
Tizanidine—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.0165	0.0165	CcSEcCtD
Tizanidine—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.0155	0.0155	CcSEcCtD
Tizanidine—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.0153	0.0153	CcSEcCtD
Tizanidine—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.0148	0.0148	CcSEcCtD
Tizanidine—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.0144	0.0144	CcSEcCtD
Tizanidine—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.0142	0.0142	CcSEcCtD
Tizanidine—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0131	CcSEcCtD
Tizanidine—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0125	CcSEcCtD
Tizanidine—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0123	CcSEcCtD
Tizanidine—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0113	CcSEcCtD
Tizanidine—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0113	CcSEcCtD
Tizanidine—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0109	CcSEcCtD
Tizanidine—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0107	CcSEcCtD
Tizanidine—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.0106	CcSEcCtD
Tizanidine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.0106	CcSEcCtD
Tizanidine—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.0106	CcSEcCtD
Tizanidine—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0105	CcSEcCtD
Tizanidine—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00985	0.00985	CcSEcCtD
Tizanidine—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00977	0.00977	CcSEcCtD
Tizanidine—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00973	0.00973	CcSEcCtD
Tizanidine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00934	0.00934	CcSEcCtD
Tizanidine—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00934	0.00934	CcSEcCtD
Tizanidine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00899	0.00899	CcSEcCtD
Tizanidine—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.0087	0.0087	CcSEcCtD
Tizanidine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00837	0.00837	CcSEcCtD
Tizanidine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.0082	0.0082	CcSEcCtD
Tizanidine—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00789	0.00789	CcSEcCtD
Tizanidine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00758	0.00758	CcSEcCtD
Tizanidine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00742	0.00742	CcSEcCtD
Tizanidine—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0074	0.0074	CcSEcCtD
Tizanidine—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00736	0.00736	CcSEcCtD
Tizanidine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00729	0.00729	CcSEcCtD
Tizanidine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00721	0.00721	CcSEcCtD
Tizanidine—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00719	0.00719	CcSEcCtD
Tizanidine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00717	0.00717	CcSEcCtD
Tizanidine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00717	0.00717	CcSEcCtD
Tizanidine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00713	0.00713	CcSEcCtD
Tizanidine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00711	0.00711	CcSEcCtD
Tizanidine—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00697	0.00697	CcSEcCtD
Tizanidine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00692	0.00692	CcSEcCtD
Tizanidine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00686	0.00686	CcSEcCtD
Tizanidine—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.0066	0.0066	CcSEcCtD
Tizanidine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00658	0.00658	CcSEcCtD
Tizanidine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00657	0.00657	CcSEcCtD
Tizanidine—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00657	0.00657	CcSEcCtD
Tizanidine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00652	0.00652	CcSEcCtD
Tizanidine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00648	0.00648	CcSEcCtD
Tizanidine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00645	0.00645	CcSEcCtD
Tizanidine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00644	0.00644	CcSEcCtD
Tizanidine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00612	0.00612	CcSEcCtD
Tizanidine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00596	0.00596	CcSEcCtD
Tizanidine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00592	0.00592	CcSEcCtD
Tizanidine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00587	0.00587	CcSEcCtD
Tizanidine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.0058	0.0058	CcSEcCtD
Tizanidine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00575	0.00575	CcSEcCtD
Tizanidine—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00563	0.00563	CcSEcCtD
Tizanidine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00561	0.00561	CcSEcCtD
Tizanidine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00555	0.00555	CcSEcCtD
Tizanidine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.0055	0.0055	CcSEcCtD
Tizanidine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00539	0.00539	CcSEcCtD
Tizanidine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00536	0.00536	CcSEcCtD
Tizanidine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0053	0.0053	CcSEcCtD
Tizanidine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00528	0.00528	CcSEcCtD
Tizanidine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00525	0.00525	CcSEcCtD
Tizanidine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.00515	CcSEcCtD
Tizanidine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00514	0.00514	CcSEcCtD
Tizanidine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00512	0.00512	CcSEcCtD
Tizanidine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00495	0.00495	CcSEcCtD
Tizanidine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00493	0.00493	CcSEcCtD
Tizanidine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.00487	CcSEcCtD
Tizanidine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00485	0.00485	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00483	0.00483	CcSEcCtD
Tizanidine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00481	0.00481	CcSEcCtD
Tizanidine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00476	0.00476	CcSEcCtD
Tizanidine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.0047	0.0047	CcSEcCtD
Tizanidine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.00466	CcSEcCtD
Tizanidine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.00466	CcSEcCtD
Tizanidine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.00463	CcSEcCtD
Tizanidine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00457	0.00457	CcSEcCtD
Tizanidine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00457	0.00457	CcSEcCtD
Tizanidine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00453	0.00453	CcSEcCtD
Tizanidine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00451	0.00451	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00425	0.00425	CcSEcCtD
Tizanidine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00419	0.00419	CcSEcCtD
Tizanidine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00416	0.00416	CcSEcCtD
Tizanidine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00415	0.00415	CcSEcCtD
Tizanidine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00411	0.00411	CcSEcCtD
Tizanidine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.00402	CcSEcCtD
Tizanidine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00399	0.00399	CcSEcCtD
Tizanidine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00384	0.00384	CcSEcCtD
Tizanidine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00381	0.00381	CcSEcCtD
Tizanidine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00371	0.00371	CcSEcCtD
Tizanidine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00369	0.00369	CcSEcCtD
Tizanidine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00369	0.00369	CcSEcCtD
Tizanidine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00344	0.00344	CcSEcCtD
Tizanidine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00335	0.00335	CcSEcCtD
Tizanidine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.0033	CcSEcCtD
Tizanidine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.00319	CcSEcCtD
Tizanidine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.00308	CcSEcCtD
Tizanidine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.00297	CcSEcCtD
Tizanidine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00294	0.00294	CcSEcCtD
Tizanidine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00294	0.00294	CcSEcCtD
Tizanidine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00277	0.00277	CcSEcCtD
